Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2325)
All Articles published online
|
Feb 21, 2007 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bergheim I, Wolfgarten E, Bollschweiler E, Hölscher A, Bode C, Parlesak A. Cytochrome P450 levels are altered in patients with esophageal squamous-cell carcinoma. World J Gastroenterol 2007; 13(7): 997-1002 [PMID: 17373732 DOI: 10.3748/wjg.v13.i7.997] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i7/997.htm |
| Number | Citing Articles |
| 1 |
Yan-Mei Guo, Qin Wang, Yan-Zhen Liu, Huei-Min Chen, Zhi Qi, Qing-Hong Guo. Genetic polymorphisms in cytochrome P4502E1, alcohol and aldehyde dehydrogenases and the risk of esophageal squamous cell carcinoma in Gansu Chinese males. World Journal of Gastroenterology 2008; 14(9): 1444-1449 doi: 10.3748/wjg.14.1444
|
| 2 |
Madhu S. Singh, Michael Michael. Cancer Epidemiology. Methods in Molecular Biology 2009; 472: 243 doi: 10.1007/978-1-60327-492-0_10
|
| 3 |
Adam N. Bennett, Rui Xuan Huang, Qian He, Nikki P. Lee, Wing-Kin Sung, Kei Hang Katie Chan. Drug repositioning for esophageal squamous cell carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.991842
|
| 4 |
Zhenzhen Jiang, Xiaoli Zheng, Weijia Wang, Liqing Qiu, Lingrong Yang, Mingfeng Jiang, Yuhui Hua. CYP2C9 inhibits the invasion and migration of esophageal squamous cell carcinoma via downregulation of HDAC. Molecular and Cellular Biochemistry 2021; 476(5): 2011 doi: 10.1007/s11010-021-04050-3
|
| 5 |
Nicholas S. Luke, Reeder Sams, Michael J. DeVito, Rory B. Conolly, Hisham A. El-Masri. Development of a Quantitative Model Incorporating Key Events in a Hepatotoxic Mode of Action to Predict Tumor Incidence. Toxicological Sciences 2010; 115(1): 253 doi: 10.1093/toxsci/kfq021
|
| 6 |
Gunda Millonig, Ying Wang, Nils Homann, Friederike Bernhardt, Hua Qin, Sebastian Mueller, Helmut Bartsch, Helmut K. Seitz. Ethanol‐mediated carcinogenesis in the human esophagus implicates CYP2E1 induction and the generation of carcinogenic DNA‐lesions. International Journal of Cancer 2011; 128(3): 533 doi: 10.1002/ijc.25604
|
| 7 |
Xiaowu Zhong, Guangcheng Huang, Qiang Ma, Hebin Liao, Chang Liu, Wenjie Pu, Lei Xu, Yan Cai, Xiaolan Guo. Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis. Medicine 2019; 98(27): e16269 doi: 10.1097/MD.0000000000016269
|
| 8 |
Shuang Chen, Xiao Xiao, Jianliang Chen, Yun Chen, Zixian Wang, Guodong Qiu, Shuyao Zhang, Shilong Zhong. XRCC1, ABCB1, CYP3A5 and GSTP1 gene polymorphism associated with platinum‐based drugs induced hematotoxicity in Chinese oesophageal cancer patients. Medicine Advances 2023; 1(2): 133 doi: 10.1002/med4.22
|
| 9 |
Polat Dura, Tineke Berkers, Elke M van Veen, Jody Salomon, Rene HM te Morsche, Hennie MJ Roelofs, Jon O Kristinsson, Theo Wobbes, Ben JM Witteman, Adriaan CITL Tan, Joost PH Drenth, Wilbert HM Peters. Polymorphisms in alcohol-metabolizing enzymes and esophageal carcinoma susceptibility: a Dutch Caucasian case–control study. Journal of Human Genetics 2013; 58(11): 742 doi: 10.1038/jhg.2013.95
|
| 10 |
Elisa M Noll, Christian Eisen, Albrecht Stenzinger, Elisa Espinet, Alexander Muckenhuber, Corinna Klein, Vanessa Vogel, Bernd Klaus, Wiebke Nadler, Christoph Rösli, Christian Lutz, Michael Kulke, Jan Engelhardt, Franziska M Zickgraf, Octavio Espinosa, Matthias Schlesner, Xiaoqi Jiang, Annette Kopp-Schneider, Peter Neuhaus, Marcus Bahra, Bruno V Sinn, Roland Eils, Nathalia A Giese, Thilo Hackert, Oliver Strobel, Jens Werner, Markus W Büchler, Wilko Weichert, Andreas Trumpp, Martin R Sprick. CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma. Nature Medicine 2016; 22(3): 278 doi: 10.1038/nm.4038
|
| 11 |
Nathália Moreno Cury, Anelise Russo, Ana Lívia Silva Galbiatti, Mariângela Torreglosa Ruiz, Luiz Sérgio Raposo, José Victor Maniglia, Érika Cristina Pavarino, Eny Maria Goloni-Bertollo. Polymorphisms of the CYP1A1 and CYP2E1 genes in head and neck squamous cell carcinoma risk. Molecular Biology Reports 2012; 39(2): 1055 doi: 10.1007/s11033-011-0831-1
|
| 12 |
Moritz Schmelzle, Levent Dizdar, Hanno Matthaei, Stephan E. Baldus, Judith Wolters, Nina Lindenlauf, Ingmar Bruns, Ron-Patrick Cadeddu, Feride Kröpil, Stefan A. Topp, Jan Schulte am Esch, Claus F. Eisenberger, Wolfram T. Knoefel, Nikolas H. Stoecklein. Esophageal cancer proliferation is mediated by cytochrome P450 2C9 (CYP2C9). Prostaglandins & Other Lipid Mediators 2011; 94(1-2): 25 doi: 10.1016/j.prostaglandins.2010.12.001
|
| 13 |
XiaoPing Pan, JianZhou Li, WeiBo Du, XiaoPeng Yu, ChunXia Zhu, ChengBo Yu, HongCui Cao, YiMin Zhang, Yu Chen, LanJuan Li. Establishment and characterization of immortalized human hepatocyte cell line for applications in bioartificial livers. Biotechnology Letters 2012; 34(12): 2183 doi: 10.1007/s10529-012-1025-1
|
| 14 |
Feng-Feng Gong, Shan-Shan Lu, Cai-Yun Hu, Zhen-Zhong Qian, Fang Feng, Yi-Le Wu, Hui-Yun Yang, Ye-Huan Sun. Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies. Tumor Biology 2014; 35(10): 10351 doi: 10.1007/s13277-014-2341-y
|
| 15 |
Ingrid Fleming. Vascular Cytochrome P450 Enzymes: Physiology and Pathophysiology. Trends in Cardiovascular Medicine 2008; 18(1): 20 doi: 10.1016/j.tcm.2007.11.002
|
| 16 |
Sudha Sharma, Papori Sharma, Tara Bailey, Susmita Bhattarai, Utsab Subedi, Chloe Miller, Hosne Ara, Srivatsan Kidambi, Hong Sun, Manikandan Panchatcharam, Sumitra Miriyala. Electrophilic Aldehyde 4-Hydroxy-2-Nonenal Mediated Signaling and Mitochondrial Dysfunction. Biomolecules 2022; 12(11): 1555 doi: 10.3390/biom12111555
|
| 17 |
Gabriel Kigen, Naftali Busakhala, Zipporah Kamuren, Hillary Rono, Wilfred Kimalat, Evangeline Njiru. Factors associated with the high prevalence of oesophageal cancer in Western Kenya: a review. Infectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0169-y
|
| 18 |
Gulzar Ahmad Bhat, Idrees Ayoub Shah, Muzamil Ashraf Makhdoomi, Beenish Iqbal, Rumaisa Rafiq, Sumaiya Nabi, Akbar Masood, Mohd Maqbool Lone, Nazir Ahmad Dar. CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir. Tumor Biology 2014; 35(6): 5323 doi: 10.1007/s13277-014-1694-6
|
| 19 |
Sheena Sharma, Deepak Suresh Ahire, Bhagwat Prasad. Utility of Quantitative Proteomics for Enhancing the Predictive Ability of Physiologically Based Pharmacokinetic Models Across Disease States. The Journal of Clinical Pharmacology 2020; 60(S1) doi: 10.1002/jcph.1709
|
| 20 |
Dianliang Wang, Min Su, Dongping Tian, Shuang Liang, Jing Zhang. Associations between CYP1A1 and CYP2E1 polymorphisms and susceptibility to esophageal cancer in Chaoshan and Taihang areas of China. Cancer Epidemiology 2012; 36(3): 276 doi: 10.1016/j.canep.2011.10.008
|
| 21 |
Xiangkun Wang, Tingdong Yu, Xiwen Liao, Chengkun Yang, Chuangye Han, Guangzhi Zhu, Ketuan Huang, Long Yu, Wei Qin, Hao Su, Xiaoguang Liu, Tao Peng. The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma. Cancer Medicine 2018; 7(4): 966 doi: 10.1002/cam4.1299
|
| 22 |
Nataliya Pidkovka, Olena Rachkevych, Abbes Belkhiri. Extrahepatic cytochrome P450 epoxygenases: pathophysiology and clinical significance in human gastrointestinal cancers. Oncotarget 2021; 12(4): 379 doi: 10.18632/oncotarget.27893
|
| 23 |
ShuTao Zheng, Lucine Vuitton, Ilyar Sheyhidin, Dominique Angèle Vuitton, YueMing Zhang, XiaoMei Lu. Northwestern China. European Journal of Gastroenterology & Hepatology 2011; 23(12): 1087 doi: 10.1097/MEG.0b013e32834a14d9
|